Reflux Esophagitis Phase III Study (Maintenance Treatment)

NCT00634114 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

540

Enrollment

INDUSTRY

Sponsor class

Conditions

Reflux Esophagitis

Interventions

DRUG: Esomeprazole
DRUG: Esomeprazole
DRUG: Omeprazole

Sponsor

AstraZeneca